- Home
- GTBP vs EVOK Comparison
GTBP vs EVOK Comparison
Compare GTBP & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- EVOK
- Stock Information
- Founded
- GTBP 1965
- EVOK 2007
- Country
- GTBP United States
- EVOK United States
- Employees
- GTBP N/A
- EVOK N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- GTBP Health Care
- EVOK Health Care
- Exchange
- GTBP Nasdaq
- EVOK Nasdaq
- Market Cap
- GTBP 5.5M
- EVOK 5.4M
- IPO Year
- GTBP N/A
- EVOK 2013
- Fundamental
- Price
- GTBP $1.77
- EVOK $5.45
- Analyst Decision
- GTBP Strong Buy
- EVOK
- Analyst Count
- GTBP 1
- EVOK 0
- Target Price
- GTBP $11.00
- EVOK N/A
- AVG Volume (30 Days)
- GTBP 74.2K
- EVOK 7.3M
- Earning Date
- GTBP 08-13-2025
- EVOK 08-12-2025
- Dividend Yield
- GTBP N/A
- EVOK N/A
- EPS Growth
- GTBP N/A
- EVOK N/A
- EPS
- GTBP N/A
- EVOK N/A
- Revenue
- GTBP N/A
- EVOK $11,594,083.00
- Revenue This Year
- GTBP N/A
- EVOK $57.82
- Revenue Next Year
- GTBP N/A
- EVOK $59.12
- P/E Ratio
- GTBP N/A
- EVOK N/A
- Revenue Growth
- GTBP N/A
- EVOK 89.89
- 52 Week Low
- GTBP $1.72
- EVOK $1.94
- 52 Week High
- GTBP $4.10
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- GTBP 31.45
- EVOK 63.18
- Support Level
- GTBP $2.01
- EVOK $3.43
- Resistance Level
- GTBP $2.11
- EVOK $5.65
- Average True Range (ATR)
- GTBP 0.14
- EVOK 0.51
- MACD
- GTBP -0.01
- EVOK 0.02
- Stochastic Oscillator
- GTBP 8.77
- EVOK 90.99
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.